Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Assets Average: 2014-2025

Historic Assets Average for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Sep 2025 value amounting to $1.6 billion.

  • Amphastar Pharmaceuticals' Assets Average rose 8.06% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 8.06%. This contributed to the annual value of $1.5 billion for FY2024, which is 37.05% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Assets Average stood at $1.6 billion for Q3 2025, which was up 1.23% from $1.6 billion recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Assets Average high stood at $1.6 billion for Q3 2025, and its period low was $638.5 million during Q1 2021.
  • For the 3-year period, Amphastar Pharmaceuticals' Assets Average averaged around $1.4 billion, with its median value being $1.5 billion (2024).
  • Data for Amphastar Pharmaceuticals' Assets Average shows a peak YoY spiked of 108.18% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Amphastar Pharmaceuticals' Assets Average stood at $661.6 million in 2021, then rose by 10.99% to $734.3 million in 2022, then surged by 108.18% to $1.5 billion in 2023, then grew by 2.13% to $1.6 billion in 2024, then climbed by 8.06% to $1.6 billion in 2025.
  • Its Assets Average stands at $1.6 billion for Q3 2025, versus $1.6 billion for Q2 2025 and $1.6 billion for Q1 2025.